CDH1 and breast neoplasm: A partial or total loss of E-cadherin expression and/or function(s) has been reported in numerous tumors of epithelial origin, among them in breast tumors, leading to destabilization of cell-cell interactions and aberrant activation of cellular signaling pathways [3, 4].